Alkem Laboratories
- All
- News
- Videos
-
Sensex Ends 30 Points Lower, Falls 1% For The Week
Indian stock markets look more vulnerable than other emerging markets due to the ongoing demonetisation drive and its possible heavy impact on corporate performances.
-
Alkem Laboratories Shares Slump On USFDA Observations
The Mumbai-based pharmaceuticals company said the US health regulator had conducted an inspection at the Ankleshwar facility from December 5 to December 9.
-
Alkem Gets 3 Observations From US Regulator After Ankleshwar Unit Inspection
Alkem Laboratories said it will put together a detailed response with adequate corrective and preventive measures to address the FDA's observations and the same is proposed to be filed within the time line stipulated by the US regulator.
-
Alkem Laboratories Slumps After US FDA's Observations On Daman Plant
Alkem Laboratories said that the US regulator had conducted an inspection at the company's manufacturing facility located at Daman from September 20 to September 29, 2016.
-
US Regulator Makes 13 Observations Against Alkem's Daman Plant
Drug firm Alkem Laboratories on Thursday said it has received an inspection report with thirteen observations from the US health regulator after inspection of its manufacturing facility at Daman.
-
Alkem Lab Rises 3% on Successful FDA Inspection Of Facility
Shares of Alkem Laboratories rose as much as 3 per cent to Rs 1,625 after the pharma company announced successful inspection of its Taloja, Maharashtra, facility by the US regulator.
-
Alkem's Taloja Facility Cleared By UK Health Regulator
Drug firm Alkem Laboratories on Tuesday said the UK health regulator has given a clean chit to its Taloja facility in Maharashtra after going through the corrective and preventive steps submitted by the company.
-
Prices Of Cancer, Diabetes, Blood Pressure Drugs Cut By Around 25%
Prices of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and blood pressure have been capped by the government thereby reducing the cost by an average of around 25 per cent.
-
Thyrocare IPO Subscribed 56% On Day 1
The initial public offering (IPO) of diagnostics company Thyrocare Technologies has been subscribed 56 per cent on the first day of the issue on Wednesday.
-
Thyrocare Technologies IPO To Open On April 27
Diagnostics company Thyrocare Technologies will hit the capital markets on April 27 to raise funds through an initial public offering.
-
Alkem Labs Shares Fall On Row Over Fudging Trial Data
Alkem Laboratories shares fell as much as 8 per cent on Monday after the company confirmed it was in talks with German authorities who had accused it of fudging data in some clinical trials.
-
Alkem Labs Accused Of Fudging Trial Data By German Regulator
Alkem was found to have engaged in "intentional misrepresentation" of data and duplicated results of electrocardiogram (ECG) readings of patients in trials, the German regulator said in a notice sent to the EMA on March 24, 2016.
-
Alkem Lab Shares Dip 7% On UKMHRA Observations
Shares of Alkem Laboratories today fell by 7 per cent as the UK health regulator made eight observations after inspecting its manufacturing plant at Taloja, Maharashtra.
-
Tribunal Stays Fair Trade Regulator's Ruling Against Alkem Labs
The Competition Appellate Tribunal has stayed an order by the Competition Commission of India's (CCI) imposing a penalty of over Rs 74 crore on Alkem Laboratories.
-
Plan to Launch 5-10 Products in US Over Two Years: Alkem Lab
Alkem Laboratories' debut in stock markets has been nothing short of phenomenal, with its shares gaining 47 per cent in two trading sessions.
-
Sensex Ends 30 Points Lower, Falls 1% For The Week
Indian stock markets look more vulnerable than other emerging markets due to the ongoing demonetisation drive and its possible heavy impact on corporate performances.
-
Alkem Laboratories Shares Slump On USFDA Observations
The Mumbai-based pharmaceuticals company said the US health regulator had conducted an inspection at the Ankleshwar facility from December 5 to December 9.
-
Alkem Gets 3 Observations From US Regulator After Ankleshwar Unit Inspection
Alkem Laboratories said it will put together a detailed response with adequate corrective and preventive measures to address the FDA's observations and the same is proposed to be filed within the time line stipulated by the US regulator.
-
Alkem Laboratories Slumps After US FDA's Observations On Daman Plant
Alkem Laboratories said that the US regulator had conducted an inspection at the company's manufacturing facility located at Daman from September 20 to September 29, 2016.
-
US Regulator Makes 13 Observations Against Alkem's Daman Plant
Drug firm Alkem Laboratories on Thursday said it has received an inspection report with thirteen observations from the US health regulator after inspection of its manufacturing facility at Daman.
-
Alkem Lab Rises 3% on Successful FDA Inspection Of Facility
Shares of Alkem Laboratories rose as much as 3 per cent to Rs 1,625 after the pharma company announced successful inspection of its Taloja, Maharashtra, facility by the US regulator.
-
Alkem's Taloja Facility Cleared By UK Health Regulator
Drug firm Alkem Laboratories on Tuesday said the UK health regulator has given a clean chit to its Taloja facility in Maharashtra after going through the corrective and preventive steps submitted by the company.
-
Prices Of Cancer, Diabetes, Blood Pressure Drugs Cut By Around 25%
Prices of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and blood pressure have been capped by the government thereby reducing the cost by an average of around 25 per cent.
-
Thyrocare IPO Subscribed 56% On Day 1
The initial public offering (IPO) of diagnostics company Thyrocare Technologies has been subscribed 56 per cent on the first day of the issue on Wednesday.
-
Thyrocare Technologies IPO To Open On April 27
Diagnostics company Thyrocare Technologies will hit the capital markets on April 27 to raise funds through an initial public offering.
-
Alkem Labs Shares Fall On Row Over Fudging Trial Data
Alkem Laboratories shares fell as much as 8 per cent on Monday after the company confirmed it was in talks with German authorities who had accused it of fudging data in some clinical trials.
-
Alkem Labs Accused Of Fudging Trial Data By German Regulator
Alkem was found to have engaged in "intentional misrepresentation" of data and duplicated results of electrocardiogram (ECG) readings of patients in trials, the German regulator said in a notice sent to the EMA on March 24, 2016.
-
Alkem Lab Shares Dip 7% On UKMHRA Observations
Shares of Alkem Laboratories today fell by 7 per cent as the UK health regulator made eight observations after inspecting its manufacturing plant at Taloja, Maharashtra.
-
Tribunal Stays Fair Trade Regulator's Ruling Against Alkem Labs
The Competition Appellate Tribunal has stayed an order by the Competition Commission of India's (CCI) imposing a penalty of over Rs 74 crore on Alkem Laboratories.
-
Plan to Launch 5-10 Products in US Over Two Years: Alkem Lab
Alkem Laboratories' debut in stock markets has been nothing short of phenomenal, with its shares gaining 47 per cent in two trading sessions.
